Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,155,000 | 896,000 | 1,058,000 | 1,022,000 | 925,000 |
| Cost of Goods | 84,000 | 65,000 | 81,000 | 58,000 | 57,000 |
| Gross Profit | 1,071,000 | 831,000 | 977,000 | 964,000 | 868,000 |
| Operating Expenses | 696,000 | 651,000 | 919,000 | 505,000 | 508,000 |
| Operating Income | 375,000 | 180,000 | 58,000 | 459,000 | 360,000 |
| Interest Expense | 139,000 | 150,000 | 96,000 | 37,000 | 91,000 |
| Other Income | 59,000 | 44,000 | 93,000 | 60,000 | 154,000 |
| Pre-tax Income | 295,000 | 74,000 | 55,000 | 482,000 | 423,000 |
| Income Tax | -8,000 | 21,000 | 24,000 | 81,000 | 87,000 |
| Net Income Continuous | 303,000 | 53,000 | 31,000 | 401,000 | 336,000 |
| Net Income | $303,000 | $53,000 | $31,000 | $401,000 | $336,000 |
| EPS Basic Total Ops | 0.49 | 0.08 | 0.05 | 0.65 | 0.54 |
| EPS Basic Continuous Ops | 0.49 | 0.08 | 0.05 | 0.65 | 0.54 |
| EPS Diluted Total Ops | 0.49 | 0.08 | 0.04 | 0.65 | 0.54 |
| EPS Diluted Continuous Ops | 0.49 | 0.08 | 0.04 | 0.65 | 0.54 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.15 | 0.05 | 0.65 | 0.54 |
| EBITDA(a) | $401,000 | $209,000 | $79,000 | $477,000 | $376,000 |